Sign In  |  Register  |  About Sunnyvale  |  Contact Us

Sunnyvale, CA
September 01, 2020 10:10am
7-Day Forecast | Traffic

  • Search Hotels in Sunnyvale

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Viatris Inc (NQ: VTRS )

10.85 -0.05 (-0.46%)
Streaming Delayed Price Updated: 9:50 AM EDT, Jun 29, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 277,517
Open 10.94
Bid (Size) 10.84 (77)
Ask (Size) 10.85 (1)
Prev. Close 10.90
Today's Range 10.82 - 10.95
52wk Range 9.660 - 15.60
Shares Outstanding 1,212,301,241
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2022
Upgrades 
Via Benzinga
7 High-Quality Dividend Stocks With High Yields
These are the best dividend stocks with high yields to invest in now. BIP, EPR, FL, KMI, KHC, VTRS, and WBA can make great investments. 
Via InvestorPlace

Performance

YTD
-23.64%
-23.64%
1 Month
-11.57%
-11.57%
3 Month
-2.95%
-2.95%
6 Month
-15.06%
-15.06%
1 Year
-24.55%
-24.55%

More News

Read More
Looking Into Viatris's Return On Capital Employed
Via Benzinga
Expert Ratings for Viatris
Via Benzinga
Viatris Posts Q1 Profit Despite 5% Dip In Sales, Reiterates FY22 Guidance Above Consensus
Via Benzinga
Recap: Viatris Q1 Earnings
Via Benzinga
Viatris' Mylan Recalls One Batch Of Insulin Glargine Due To Missing Label
Via Benzinga
Revolutionary Heart Therapy Offers Hope to Patients and Investors Alike
Via FinancialNewsMedia
Current Report: Viatris
Via Talk Markets
3 Top S&P 500 Stock Market Gainers Today
Via Investor's Business Daily
27 Recession-Resistant Stocks To Look At Now
Via Benzinga
High Dividend 50: Viatris
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2022
Via Benzinga
Pfizer: What Comes After the Covid-19 Fire?
Via InvestorPlace
The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More
Via Benzinga
Earnings Scheduled For May 9, 2022
Via Benzinga
Biogen’s Aduhelm Crashes the Biotech Sector
Via InvestorPlace
The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight
Via Benzinga
7 Cheap Stocks to Buy Now if You Have $100 to Spend
Via InvestorPlace
35 Generic Drugmakers Sign To Manufacture Low-Cost Version Of Pfizer's COVID Pill
Via Benzinga
7 Drug Stocks to Consider After the Viatris Plunge
Via InvestorPlace
AbbVie, Alvotech Resolve US Patent Dispute Related To Humira Biosimilar
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022
Via Benzinga
Viatris's Return On Capital Employed Overview
Via Benzinga
67 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Sunnyvale.com & California Media Partners, LLC. All rights reserved.